GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HCmed Innovations Co Ltd (ROCO:6934) » Definitions » DeferredTaxAndRevenue

HCmed Innovations Co (ROCO:6934) DeferredTaxAndRevenue : NT$0.0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is HCmed Innovations Co DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

HCmed Innovations Co's current deferred tax and revenue for the quarter that ended in Dec. 2024 was NT$0.0 Mil.

HCmed Innovations Co DeferredTaxAndRevenue Historical Data

The historical data trend for HCmed Innovations Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HCmed Innovations Co DeferredTaxAndRevenue Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue
- - - -

HCmed Innovations Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

HCmed Innovations Co DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of HCmed Innovations Co's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


HCmed Innovations Co Business Description

Traded in Other Exchanges
N/A
Address
Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine.

HCmed Innovations Co Headlines

No Headlines